Publications

  1. Bristow, Greg C; Bostrom, John A; Haroutunian, Vahram; Sodhi, Monsheel S; Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia. Schizophrenia research (2015). In press.
  2. Bonaccorso, Stefania; Sodhi, Monsheel; Li, Jiang; Bobo, William V; Chen, Yuejin; Tumuklu, Mevhibe; Theleritis, Christos; Jayathilake, Karuna; Meltzer, Herbert Y; The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia. Bipolar disorders (2015). In press.
  3. Sodhi, Monsheel; Gray, Angel; Deep-Soboslay, Amy; Hyde, Thomas M; Kleinman, Joel E; Sex Differences in the Glutamate System in Major Depression and Suicide. Neuropsychopharmacology (2014) 39, 470.
  4. Sodhi Monsheel; Hyde, Thomas M; Kleinman, Joel E; Genetic Regulation of the Glutamate System is Disrupted in Major Depression and Schizophrenia. Biological Psychiatry (2014) 75, 9: 24.
  5. Bostrom John A, Sodhi Monsheel S. A Look to the Future: Epigenetics in Psychiatric Disorders and Treatment. In: Lam YWF, Cavallari LH (eds). Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation (2013). Elsevier Inc: Maryland Heights, MO. p.225-246.
  6. Hanson R, Gannon M, Khamo N, Sodhi MS, Orr A, Stubbings J . Improvement in Safety Monitoring of Biologic Response Modifiers After the Implementation of Clinical Care Guidelines by a Specialty Pharmacy Service in an Academic Health System. J Managed Care Pharmacy (2013), 19 (1): 49-67. PMID: 23383700.
  7. Sodhi MS, Simmons M, McCullumsmith R, Haroutunian V, Meador-Woodruff JH (2011). Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia. Biological Psychiatry 70:646-654. PMID: 21549355. [Link]
  8. Simmons M, Meador-Woodruff JH, Sodhi MS (2010). Increased cortical expression of an RNA editing enzyme occurs in major depressive suicide victims. Neuroreport 21(15):993-7.PMID: 20802353. [Link]
  9. Roth TL, Lubin FD, Sodhi M, Kleinman JE (2009). Epigenetics and schizophrenia. Biochim Biophys Acta;1790(9):869-77. PMID: 19559755 Times cited=37. [Link]
  10. Sodhi MS, Wood KH, Meador-Woodruff JH (2008). Role of glutamate in schizophrenia: integrating excitatory avenues of research. Exp Review Neurother 8(9), 1389-1406. PMID:18759551 Times cited=23. [Link]
  11. Hackler EA, Airey DC, Shannon CC, Sodhi MS, Sanders-Bush E (2006). 5-HT2C receptor RNA editing in the amygdala of inbred strains: implications for anxiety and fear. Neurosci Res 55(1):96-104. PMID: 16580757 Times cited=36. [Link]
  12. Sodhi MS, Airey DC, Lamber W, Burnet PW, Harrison PJ, Sanders-Bush E (2005). A rapid new assay to detect RNA editing reveals antipsychotic-induced changes in serotonin-2C transcripts. Mol Pharmacol 68: 711-719. PMID: 15917433 Times cited=28. [Link]
  13. Pooley EC, Fairburn CG, Cooper Z, Sodhi MS, Cowen PJ, Harrison PJ (2004). A 5-HT2C receptor promoter polymorphism (HTR2C - 759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes. Am J Med Genet (Neuropsychiat Genet). 126B: 124-7. PMID: 15048662 Times cited=50. [Link]
  14. Sodhi MS, Sanders-Bush E (2004). Serotonin and brain development. Int Rev Neurobiol. 2004;59:111-74. PMID:15006487 Times cited=122. [Link]
  15. Tunbridge, E., Burnet PJ, Sodhi MS, Harrison PJ (2004). "Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression." Synapse 51(2):112-8. PMID: 14618678 Times cited=50. [Link]
  16. Sodhi MS, Burnet PJ, Makoff AJ and Harrison PJ (2001). Reduced mRNA editing of the human 5-HT2C receptor in schizophrenia. Molecular Psychiatry, 6 (4), 373-9. PMID: 11443520 Times cited=109. [Link]
  17. Arranz MJ, Munro J, Birkett J, Bolonna A, Mancama D, Sodhi MS, et al. (2000). Pharmacogenetic prediction of clozapine response. Lancet 355: 1615 - 1616. PMID: 10821369 Times cited=196. [Link]
  18. Arranz MJ, Erdmann J, Kirov G, Rietschel M, Sodhi MS, et al. (1997). 5-HT2A receptor and bipolar affective disorder: Association studies in affected patients. Neurosci Lett 224 (2): 95-98. PMID:9086465 Times cited=46. [Link]
  19. Sodhi MS (2000). The role of the 5-HT2 serotonin receptor subtypes in psychosis: a pharmacogenetic study. Thesis, Kings College, University of London, U.K.
  20. Sodhi MS, Murray RM (1997). Future therapies for schizophrenia. Expert Opinion on Therapeutic Patients 7(2): 151-165. Times cited=7.[Link]
  21. Collier DA, Arranz M, Sham P, Battersby S, Gill P, Aitchison KJ, Sodhi MS, et al. (1996). The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. NeuroReport 7(10):1675-1679. PMID: 8904780 Times cited=149.[Link]
  22. Arranz MJ, Collier DA, Munro J, Sham P, Kirov G, Sodhi MS, Roberts GW, Price J, and Kerwin RW (1996). Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neuroscience Letters 217:177-178. PMID:8916101 Times cited=81.[Link]
  23. Sodhi MS, Arranz MJ, Curtis DA, Sham PC, Ball DM, Roberts GW, Price J, Collier DA and Kerwin RW (1995). Association between clozapine response and allelic variation in the 5-HT2C receptor gene. NeuroReport 7(1): 169-172. PMID: 8742444 Times cited=135. [Link]
  24. Arranz MJ, Collier D, Sodhi MS, Ball DM, Roberts GW, Price J, Sham P and Kerwin R (1995). Association between clozapine response and allelic variation in the 5-HT2A receptor gene. Lancet, 346: 281-282. PMID: 7630250 Times cited=268 [Link]